REDWOOD CITY, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CoherusOncology, Inc. (Nasdaq: CHRS), today reported financial results for the full year and fourth quarter 2025, and provided an overview of ...
With the NFL offseason less than three weeks away, where do the Chicago Bears stand heading into free agency? @AaronLemingNFL explores here: ...
Combined net unrealized and realized losses increased to $18.3 million, or $0.22 per share, from $7.5 million, or $0.09 per share, in the prior quarter, with management attributing this "mainly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results